{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:41:55Z","timestamp":1778157715529,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ygyno.2015.09.084","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T07:48:47Z","timestamp":1443858527000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer"],"prefix":"10.1016","volume":"140","author":[{"given":"Devarati","family":"Mitra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.09.084_bb0005","unstructured":"SEER Cancer Statistics Review, 1975\u20132010. National Cancer Institute. Bethesda, MD; n.d. http:\/\/seer.cancer.gov\/csr\/1975_2010\/ (accessed June 16, 2013)."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0015","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/cncr.22997","article-title":"Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.ygyno.2015.09.084_bb0020","first-page":"v41-5","article-title":"Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Plataniotis","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"562","key":"10.1016\/j.ygyno.2015.09.084_bb0030","first-page":"e1","article-title":"Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer","volume":"205","author":"Sharma","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0035","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0040","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0045","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0050","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2014a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0055","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0060","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0065","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ygyno.2005.03.008","article-title":"Predictors of vaginal relapse in stage I endometrial cancer","volume":"97","author":"Mariani","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/EN.5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0075","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2009.03.027","article-title":"Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer","volume":"114","author":"Lupe","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0095","doi-asserted-by":"crossref","unstructured":"Lupe K, Kwon J, D'Souza D, Gawlik C, Stitt L, Whiston F, et al. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach. Radiation Oncology Biology 2007;67:110\u20136. doi:http:\/\/dx.doi.org\/10.1016\/j.ijrobp.2006.08.006.","DOI":"10.1016\/j.ijrobp.2006.08.006"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2004.09.022","article-title":"A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with \u201chigh-risk\u201d endometrial cancer","volume":"96","author":"Duska","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2010.12.338","article-title":"A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a \u201csandwich\u201d method for stage III, IV, and recurrent endometrial cancer","volume":"121","author":"Geller","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2015.03.030","article-title":"Rectal bleeding after radiation therapy for endometrial cancer","volume":"115","author":"Mitra","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0115","doi-asserted-by":"crossref","unstructured":"Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Radiation Oncology Biology 1990;19:49\u201354.","DOI":"10.1016\/0360-3016(90)90133-5"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1998.5064","article-title":"The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease","volume":"70","author":"Irwin","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0125","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00000421-199908000-00003","article-title":"Surgery and postoperative radiation therapy in stage II endometrial carcinoma","volume":"22","author":"Calvin","year":"1999","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5454","article-title":"Survival of women with surgical stage II endometrial cancer","volume":"74","author":"Eltabbakh","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/gyno.1999.5380","article-title":"Predictors of recurrence in surgical stage II endometrial adenocarcinoma","volume":"73","author":"Feltmate","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0140","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0360-3016(02)02813-4","article-title":"Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients","volume":"53","author":"Pitson","year":"2002","journal-title":"Radiation Oncology Biology"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2005.04.030","article-title":"Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors","volume":"98","author":"Rittenberg","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2008.12.029","article-title":"Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma","volume":"113","author":"Cannon","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3802\/jgo.2014.25.2.105","article-title":"Survival analysis of endometrial cancer patients with cervical stromal involvement","volume":"25","author":"Frandsen","year":"2014","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0160","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e3181b0c266","article-title":"Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?","volume":"33","author":"Crosby","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0165","first-page":"4983","article-title":"Improved survival of baby boomer women with early-stage uterine cancer: a Surveillance, Epidemiology and End Results (SEER) Study","volume":"33","author":"Elshaikh","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0170","doi-asserted-by":"crossref","unstructured":"Wright JD, Fiorelli J, Kansler AL, Burke WM, Schiff PB, Cohen CJ, et al. Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation. Am J Obstet Gynecol 2009;200:419.e1\u20137. doi:10.1016\/j.ajog.2008.11.003.","DOI":"10.1016\/j.ajog.2008.11.003"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1525-1438.2001.01061.x","article-title":"Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy","volume":"11","author":"Sartori","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/gyno.2001.6276","article-title":"Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy","volume":"82","author":"Fanning","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2003.11.018","article-title":"The long-term survival of women with surgical stage II endometrioid type endometrial cancer","volume":"93","author":"Ayhan","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0190","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/AOG.0b013e3181f73fc2","article-title":"Cervical stromal invasion predicting survival in endometrial cancer","volume":"116","author":"Ferriss","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0195","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1525-1438.2007.01142.x","article-title":"Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma","volume":"18","author":"Jobsen","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0200","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2009.03.007","article-title":"Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion","volume":"113","author":"Orezzoli","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijrobp.2007.09.022","article-title":"Stage II adenocarcinoma of the endometrium: adjuvant radiotherapy and recurrence patterns","volume":"71","author":"Cozad","year":"2008","journal-title":"Radiation Oncology Biology"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0210","doi-asserted-by":"crossref","unstructured":"Paydar I, DeWees T, Powell M, Mutch DG, Grigsby PW, Schwarz JK. Adjuvant radiotherapy in stage II endometrial carcinoma: is brachytherapy alone sufficient for local control? Brachytherapy 2015;0. doi:http:\/\/dx.doi.org\/10.1016\/j.brachy.2015.02.196.","DOI":"10.1016\/j.brachy.2015.02.196"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in stage II endometrial carcinoma: is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2007.05.048","article-title":"Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis","volume":"70","author":"Rossi","year":"2008","journal-title":"Radiation Oncology Biology"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2014.12.034","article-title":"Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study","volume":"136","author":"Mahdi","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0230","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2015.06.022","article-title":"Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology","volume":"138","author":"Ly","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0235","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IGC.0000000000000248","article-title":"Adjuvant chemotherapy with external beamradiation therapy for high-grade, node-positive endometrial cancer","volume":"24","author":"Lee","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2008.06.008","article-title":"Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion","volume":"111","author":"Croog","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2009.10.043","article-title":"Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence","volume":"116","author":"Rasool","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0250","doi-asserted-by":"crossref","unstructured":"Greven KM, D'Agostino RB, Lanciano RM, Corn BW. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? Radiation Oncology Biology 1998;42:101\u20134.","DOI":"10.1016\/S0360-3016(98)00173-4"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0255","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0360-3016(96)00188-5","article-title":"Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I\/II endometrial cancer","volume":"35","author":"Algan","year":"1996","journal-title":"Radiation Oncology Biology"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1525-1438.1999.99026.x","article-title":"Adjuvant high-dose rate brachytherapy with or without external beam radiotherapy post-hysterectomy for endometrial cancer","volume":"9","author":"MacLeod","year":"1999","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0265","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.09.084_bb0270","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.09.084_bb0275","doi-asserted-by":"crossref","unstructured":"Mitra D, Nout RA, Creutzberg C, Catalano P, Cimbak N, Lee L, et al. Rectal bleeding after radiation therapy for endometrial cancer. Radiother Oncol n.d.","DOI":"10.1016\/j.radonc.2015.03.030"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2015.09.084_bb0280","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T02:33:55Z","timestamp":1567218835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0090825815301451"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.084","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}